Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
---|
01/13/2011 | US20110008795 Marker for detection of il-17-producing helper t-cell, and method for detection of il-17-producing helper t-cell |
01/13/2011 | US20110008791 Molecular Diagnosis of Bacteremia |
01/13/2011 | US20110008789 Methods and materials for treating inflammatory conditions |
01/13/2011 | US20110008787 Detection primers for nucleic acid extension or amplification reactions |
01/13/2011 | US20110008786 Methods of detecting and controlling mucoid pseudomonas biofilm production |
01/13/2011 | US20110008782 Site-specific incorporation of redox active amino acids into proteins |
01/13/2011 | US20110008772 Probes for detecting mycobacterium tuberculosis and mycobacterium tuberculosis complex and method using the same |
01/13/2011 | US20110008769 Dopaminergic neuron progenitor cell marker 187a5 |
01/13/2011 | US20110008768 Oligonucleotides and methods for detection of west nile virus |
01/13/2011 | US20110008523 Genetic sequences having methyltransferase activity and uses therefor |
01/13/2011 | US20110008393 Nucleic acids and corresponding proteins entitled 58p1d12 useful in treatment and detection of cancer |
01/13/2011 | US20110008389 Recombinant attenuated clostridium organisms and vaccine |
01/13/2011 | US20110008380 Anaplasma Phagocytophilum (Aph) Antigens and Antibodies Specific for Anaplasma |
01/13/2011 | US20110008377 Feline cd80, feline cd86, feline cd28, and feline ctla-4 nucleic acid and polypeptides |
01/13/2011 | US20110008370 Novel use of flj25416 gene |
01/13/2011 | US20110008366 Inhibition of versican with sirna and other molecules |
01/13/2011 | US20110008364 Antibodies to tgf-beta |
01/13/2011 | US20110008363 Erythropoietin variants |
01/13/2011 | US20110008358 Human monoclonal antibodies that specifically bind igf-ii |
01/13/2011 | US20110008357 Antibodies that bind il-18 and methods of inhibiting il-18 activity |
01/13/2011 | US20110008355 Anti-flt3 antibodies |
01/13/2011 | US20110008348 Soluble fragments of influenza virus pb2 protein capable of binding rna-cap |
01/13/2011 | US20110008347 Cancer-related protein kinases |
01/13/2011 | US20110008346 Biomarkers for cardiovascular disease |
01/13/2011 | US20110008345 Antigen-binding constructs |
01/13/2011 | US20110008344 Fusion partner cell line for preparation of hybrid cells expressing human antibodies |
01/13/2011 | US20110008341 Polypeptides and methods for making the same |
01/13/2011 | US20110008324 Antibody Selective for a Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor and Uses Thereof |
01/13/2011 | US20110008323 Cadherin-11 EC1 Domain Antagonists for Treating Inflammatory Joint Disorders |
01/13/2011 | US20110008319 Card domain containing polypeptides, encoding nucleic acids, and methods of use |
01/13/2011 | US20110008315 Recombinant elastase proteins and methods of manufacturing and use thereof |
01/13/2011 | US20110008311 Animal Model and Use of 17Beta-Hydroxysteroid Dehydrogenase Type 7 in the Diagnosis of Anencephaly |
01/13/2011 | US20110008309 Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases |
01/13/2011 | US20110008295 Simian adenoviruses sadv-36, -42.1, -42.2, and -44 and uses thereof |
01/13/2011 | US20110008292 Lactobacillus acidophilus nucleic acids encoding fructo-oligosaccharide utilization compounds and uses thereof |
01/13/2011 | US20110008283 Interferon fusion proteins |
01/13/2011 | US20110008256 Monoclonal antibodies that bind or neutralize dengue virus |
01/13/2011 | US20110006218 Nanodiamond compositions and methods of making and using thereof |
01/13/2011 | CA2767503A1 Long-acting coagulation factors and methods of producing same |
01/13/2011 | CA2767253A1 Novel nucleic acid prodrugs and methods of use thereof |
01/13/2011 | CA2767246A1 Tivozanib response prediction |
01/13/2011 | CA2765857A1 Method for generating aptamers with improved off-rates |
01/12/2011 | EP2273270A1 Method and apparatus for the preparation and/or analysis of biochemical carriers |
01/12/2011 | EP2272987A2 Identification of markers in esophageal cancer, colon cancer, head and neck cancer and melanoma |
01/12/2011 | EP2272985A1 Antisense modulation of apolipoprotein (A) expression |
01/12/2011 | EP2272984A1 Use of ID4 for diagnosis and treatment of cancer |
01/12/2011 | EP2272960A1 Human protein NELL2 gene |
01/12/2011 | EP2272959A1 BMP-11 compositions |
01/12/2011 | EP2272951A1 Vitamin k epoxide recycling polypeptide vkorc1, a therapeutic target of coumarin and their derivatives |
01/12/2011 | EP2272857A1 Modulation of glucagon receptor expression |
01/12/2011 | EP2272856A1 Sequence-specific nucleic acid purification method manner |
01/12/2011 | EP2272566A2 Humanisation of antibodies |
01/12/2011 | EP2271772A2 Nucleic acid-based tests for prenatal gender determination |
01/12/2011 | EP2271771A2 Process and method for monitoring gastrointestinal microbiota |
01/12/2011 | EP2271653A2 Novel method for preparing oligonucleotides comprising a 5' -phosphate monoester or 5' -thiophosphate monoester end |
01/12/2011 | EP2271366A1 Antibodies to clostridium difficile spores and uses thereof |
01/12/2011 | EP1921141B1 Novel artificial base pair and use thereof |
01/12/2011 | EP1687429B1 Promoter functional in plant plastids |
01/12/2011 | EP1537136B1 Promoters for regulation of gene expression in plant roots |
01/12/2011 | EP1472347B1 Improved protein expression in bacillus subtilis |
01/12/2011 | EP1362113B1 Constitutive promoter from arabidopsis |
01/12/2011 | CN1826411B Promoter construct for gene expression in neuronal cells |
01/12/2011 | CN101946001A Polypeptide-nucleic acid conjugates and uses thereof |
01/12/2011 | CN101942443A Novel beta-actin and rps21 promoters and uses thereof |
01/12/2011 | CN101942442A Novel beta-actin and rps21 promoters and uses thereof |
01/12/2011 | CN101200483B Antisense nucleic acid of resistant and tolerant dimethoxyphenecillin staphylococcus aureus drug resistant gene |
01/11/2011 | US7868228 DNA constructs for their expression in host cells, seed, oil and meal when the host cells comprise a plant; producing docosahexaenoic acid and eicosapentaenoic acid from plants |
01/11/2011 | US7868227 improved ability to enzymatically degrade lignocellulosic feedstocks; fermentation |
01/11/2011 | US7868226 regulate the proanthocynanidin biosynthetic pathway and proanthocynanidin biosynthesis in a plant; genetic engineering |
01/11/2011 | US7868161 detecting a target nucleic acid by detecting the presence of a fluorescent covalent crosslinked product from non-fluorescent precursors |
01/11/2011 | US7868160 Compositions and methods for inhibiting expression of anti-apoptotic genes |
01/11/2011 | US7868159 comprises negative immune regulator selected from a protein involved in molecular stability by ubiquitination, deubiquitination, and sumoylation, and a transcription factor that induces the expression of inhibitors of NF kappa B or suppresses transcription of NF kappa B targeted genes; vaccines |
01/11/2011 | US7868158 Modulation of cytokine signaling regulators and applications for immunotherapy |
01/11/2011 | US7868157 low non-specific binding, photostable, ease of chemical modification to permit tuning of absorption and emission wavelengths and resistance to the formation of dimers; 1-(5-carboxy-pentyl)-2-[5-(1-ethyl-3,3-dimethyl-5-phosphono-1,3-dihydro-indol-2-ylidene)-penta-1,3-dienyl]-3,3-dimethyl-3H-indolium |
01/11/2011 | US7868156 cultivating a transgenic plant containing a nucleotide sequences coding polypeptide, proteins and other products of interest; controlling expression of nucleic acid sequences; product is produced in seed of the plant; increase the oleic acid content of rapeseed oil |
01/11/2011 | US7868152 Capable of detecting and isolating polypeptides that are tyrosine-sulfated; used to discriminate between the non-sulfated and sulfated forms of the antibodies; useful in a wide variety of immunological protein assays and isolation procedures |
01/11/2011 | US7868151 Recombinant human interferon-like proteins |
01/11/2011 | US7868150 Nucleic acids encoding T2R taste receptors |
01/11/2011 | US7868149 Plant genome sequence and uses thereof |
01/11/2011 | US7868148 Using transposon vector as gene transfer and amplification tool; gene therapy |
01/11/2011 | US7867975 administering a nucleic acid comprising a coding region encoding endostatin; inhibiting angiogenesis in an angiogenesis-dependent site associated with macular degeneration; antiproliferative, anticarcinogenic and antitumor agents |
01/11/2011 | US7867764 replication-defective recombinant adenovirus comprising a heterologous nucleic acid sequence encoding an antigenic determinant of Plasmodium falciparum that comprises an immunogenic peptide of the circumsporozoite protein; viral vectors |
01/11/2011 | US7867748 dehydrated immobilized enzyme catalyst having improved specific activity upon rehydration; used as catalyst for the conversion of glycolonitrile to glycolic acid |
01/11/2011 | US7867746 reduced capability of cleaving a substrate close to the branching point, and improved substrate specificity; for industrial starch processing such as liquefaction or saccharification; for use in detergents, papermaking and textile treatment |
01/11/2011 | US7867744 Glucanase for biodegradation of plant biomass to be used in ethanol fermentation |
01/11/2011 | US7867743 phytases derived from Citrobacter braakii, belong to the acid histidine phosphatase family, are acid-stable, and expectedly of a high specific activity; animal feed |
01/11/2011 | US7867732 high-mannose-type sugar chain bound to a chicken antibody; BML-17; useful in medical, pharmaceutical industries, and industries relating to test agents |
01/11/2011 | US7867730 production system for a recombinant glycoprotein having therapeutic value in humans using a methylotrophic, thermotolerant yeast; host system for mass production of recombinant hepatitis vaccines |
01/11/2011 | US7867714 libraries of nucleic acid species each comprising a transcription unit having a promoter region operatively linked to a coding sequence; enable the indirect detection and analysis of particular biomolecules, for example, by mass spectrometry |
01/11/2011 | US7867711 Probe, probe set, probe-immobilized carrier, and genetic testing method |
01/11/2011 | US7867710 identifying a bovine animal as having increased susceptibility to bovine spongiform encephalopathy; selecting bovines susceptible to BSE for disposal and/or removal from breeding, the human food and animal feed supplies |
01/11/2011 | US7867708 Method of forming signal probe-polymer |
01/11/2011 | US7867707 sensitive method for the detection of low concentrations of nucleic acid analytes through use of confocal observation |
01/11/2011 | US7867706 Contacting the sample solution with a dipstick to cause sample solution to move by capillary action to a capture zone of the dipstick thereby allowing target nucleic acid in the sample solution to be captured and detected at the capture zone; diagnosising diseases caused by Chlamydia trachomatis |
01/11/2011 | US7867704 for detecting Mycobacterium paratuberculosis in a sample using nucleic acid molecules, polypeptides, and antibodies; for immunization and prevention of mycobacterial animal infections |
01/11/2011 | US7867703 uses oligonucleotide probes attached to a solid support as a sequence-specific affinity agent to isolate and facilitate the amplification of defined nucleic acid fragment mixtures |
01/11/2011 | US7867701 Method for the simultaneous amplification of multiple sequences in a PCR reaction and marking thereof |
01/11/2011 | US7867501 polypeptides derived from Streptococcus pneumoniae including surface or secreted proteins or parts thereof, that are useful as molecular targets for diagnostics, prophylaxis and treatment of bacterial infection; vaccines |
01/11/2011 | US7867491 hybrid Fc; useful as a carrier of biologically active molecules |
01/11/2011 | US7867482 treating cancer responsive to interferon alpha therapy; the protein is non-naturally occurring and has enhanced anti-viral and anti-proliferative activity in comparison to human interferon alpha 2b (HuIFN- alpha 2b) |